Endpoints News

#JPM26: Sandoz CEO on Ozempic generic launch plans for 2026

SAN FRANCISCO — Throughout his 53 meetings at this year’s JPMorgan Healthcare Conference, Richard Saynor mulled a charitable idea about the topic on everyone’s minds.

This report was first published by Endpoints News. To see the original version, click here

SAN FRANCISCO — Throughout his 53 meetings at this year’s JPMorgan Healthcare Conference, Richard Saynor mulled a charitable idea about the topic on everyone’s minds.

“We’re going to put a cup in the middle of the table,” the Sandoz CEO said. “Every time you mention GLP-1, I’m going to charge you $5. I’m going to donate it to, I don’t know, an injured Canadian seals fund or something like that.”

您已阅读15%(487字),剩余85%(2858字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归Endpoints News所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×